Cyanotech Corporation (NASDAQ:CYAN) Files An 8-K Other Events
Item 8.01.     Other Events.

As Cyanotech Corporation (the “Company”) has previously reported, the Company has been party to a litigation action initiated by Meridian OHC Partners, LP (“Meridian”) in the United States District Court, District of Nevada. The Company recently disclosed in its Form 10-Q for the quarter ended December 31, 2016 that, on January 23, 2017, the court granted the Company’s motion to dismiss the lawsuit, but granted Meridian a 20-day period to file an amended complaint. On February 13, 2017, Meridian filed an amended complaint in which the Company is not named as a defendant. As a result, the Company is no longer a party to the Meridian lawsuit.

About Cyanotech Corporation (NASDAQ:CYAN)

Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids. Hawaiian BioAstin is a dietary antioxidant shown to support and maintain the body’s natural inflammatory response, to enhance skin, and to support eye and joint health. The Company cultivates over two microalgal species from which its product lines, natural astaxanthin products and spirulina products, are derived. The Company produces its algae in Hawaii and manufactures the finished products in Hawaii and California.

Cyanotech Corporation (NASDAQ:CYAN) Recent Trading Information

Cyanotech Corporation (NASDAQ:CYAN) closed its last trading session up +0.15 at 3.90 with 5,865 shares trading hands.